STAND.
COM. REP. NO. 1079
Honolulu, Hawaii
, 2025
RE: H.B. No. 302
H.D. 2
Honorable Nadine K. Nakamura
Speaker, House of Representatives
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Madame:
Your Committee on Judiciary & Hawaiian Affairs, to which was referred H.B. No. 302, H.D. 2, entitled:
"A BILL FOR AN ACT RELATING TO CANNABIS,"
begs leave to report as follows:
Your Committee received testimony in support of this measure from the Department of Health; Aloha Green Apothecary; Cure Oahu; Hawai‘i Cannabis Industry Association; and Big Island Grown. Your Committee received comments on this measure from Akamai Cannabis Consulting.
Your Committee finds that the existing medical cannabis laws prohibit the issuance of a written certification for the use of medical cannabis by means of telehealth unless a bona fide provider-patient relationship has been previously established in person. Your Committee further finds that the laws relating to telehealth were revised in 2021, which for all other medications except for opiates and medical cannabis, allows the issuance of prescriptions through telehealth consultations without the establishment of a bona fide provider-patient relationship in person. This differentiated treatment of medical cannabis from other medications appears arbitrary and this measure eliminates this barrier, providing greater access to necessary medication for patients.
As affirmed by the record of votes of the members of your Committee on Judiciary & Hawaiian Affairs that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 302, H.D. 2, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Judiciary & Hawaiian Affairs,
|
|
|
____________________________ DAVID A. TARNAS, Chair |
|
|
|
|